119 related articles for article (PubMed ID: 32847931)
1. Cardiac abnormality in a prechemotherapy assessment for leukaemia in a 14-year-old girl.
Gavotto A; Gauthier A; Werner O
Heart; 2020 Sep; 106(18):1406-1450. PubMed ID: 32847931
[No Abstract] [Full Text] [Related]
2. Hypertrophic cardiomyopathy: identification of morphological subtypes by echocardiography and cardiac magnetic resonance imaging.
Syed IS; Ommen SR; Breen JF; Tajik AJ
JACC Cardiovasc Imaging; 2008 May; 1(3):377-9. PubMed ID: 19356452
[No Abstract] [Full Text] [Related]
3. Fibrosis suggested by 3D contrast-enhanced echocardiography in hypertrophic cardiomyopathy.
Labombarda F; Pellissier A; Saloux É
Arch Cardiovasc Dis; 2011 Dec; 104(12):680-1. PubMed ID: 22152519
[No Abstract] [Full Text] [Related]
4. Hypertrophic cardiomyopathy masquerading as sarcoidosis: cases illustrating cardiac imaging overlap relative to pathology.
Sellers SL; Ellis J; Lai A; Salcudean H; Reid AB; Blanke P; McManus BM; Leipsic JA; Seidman MA
Cardiovasc Pathol; 2020; 49():107234. PubMed ID: 32585602
[No Abstract] [Full Text] [Related]
5. Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy.
Hindieh W; Weissler-Snir A; Hammer H; Adler A; Rakowski H; Chan RH
Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794137
[TBL] [Abstract][Full Text] [Related]
6. Potential value of myocardial contrast echocardiography for the detection of myocardial fibrosis in hypertrophic cardiomyopathy.
Chaudeurge A; Garçon P; Cador R
Arch Cardiovasc Dis; 2011 Dec; 104(12):682-3. PubMed ID: 22152520
[No Abstract] [Full Text] [Related]
7. Devastating bilateral optic nerve leukaemic infiltration.
Shah P; Yohendran J; Lowe D; McCluskey P
Clin Exp Ophthalmol; 2012; 40(1):e114-5. PubMed ID: 21668784
[No Abstract] [Full Text] [Related]
8. Imaging phenotype versus genotype in hypertrophic cardiomyopathy.
Desai MY; Ommen SR; McKenna WJ; Lever HM; Elliott PM
Circ Cardiovasc Imaging; 2011 Mar; 4(2):156-68. PubMed ID: 21406662
[No Abstract] [Full Text] [Related]
9. Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.
Raiker N; Vullaganti S; Collins JD; Allen BD; Choudhury L
Int J Cardiovasc Imaging; 2020 Jun; 36(6):1147-1156. PubMed ID: 32166506
[TBL] [Abstract][Full Text] [Related]
10. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia.
Kwon DH; Smedira NG; Rodriguez ER; Tan C; Setser R; Thamilarasan M; Lytle BW; Lever HM; Desai MY
J Am Coll Cardiol; 2009 Jul; 54(3):242-9. PubMed ID: 19589437
[TBL] [Abstract][Full Text] [Related]
11. Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks.
Fahmy AS; Rausch J; Neisius U; Chan RH; Maron MS; Appelbaum E; Menze B; Nezafat R
JACC Cardiovasc Imaging; 2018 Dec; 11(12):1917-1918. PubMed ID: 30121270
[No Abstract] [Full Text] [Related]
12. Echocardiography and cardiac MRI in mutation-negative hypertrophic cardiomyopathy in an older patient: a case defining the need for ICD.
Rodriguez F; Degnan KO; Seidman CE; Mangion JR
Echocardiography; 2014 Aug; 31(7):E204-6. PubMed ID: 24816179
[TBL] [Abstract][Full Text] [Related]
13. Relapse of T-cell all after stem cell transplant presenting as hypertrophic cardiomyopathy: the value of non-invasive diagnostic imaging in detecting cardiac leukemia.
Hori T; Suzuki N; Mizue N; Hatakeyama N; Takamuro M; Tsutsumi H
Pediatr Blood Cancer; 2006 Jan; 46(1):108-11. PubMed ID: 16078227
[TBL] [Abstract][Full Text] [Related]
14. T-cell lymphoblastic leukemia as a rare cause of bilateral nephromegaly.
Akbayram S; Akgun C; Peker E; Bulut MD; Aktar F; Oner AF
J Emerg Med; 2012 Jul; 43(1):e65-6. PubMed ID: 22365528
[No Abstract] [Full Text] [Related]
15. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic detection of myocardial crypts in hypertrophic cardiomyopathy: a first report in phenotype-positive patient.
Spacek M; Fiedler J; Suchanek V; Veselka J
Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1180. PubMed ID: 24866903
[No Abstract] [Full Text] [Related]
17. Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.
Hindieh W; Chan R; Rakowski H
Curr Cardiol Rep; 2017 Sep; 19(9):81. PubMed ID: 28752280
[TBL] [Abstract][Full Text] [Related]
18. Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters.
El Saiedi S; Behairy NH; Kharabish A; Esmail R; Seliem ZS; Shafik M; El Mozy W
Pediatr Cardiol; 2017 Jun; 38(5):1024-1031. PubMed ID: 28401251
[TBL] [Abstract][Full Text] [Related]
19. Peripapillary retinal leukemic infiltration associated with papilledema in a T-ALL patient without cranial or optic nerve involvement.
Çekiç O; Biberoglu E; Esen F
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26979244
[TBL] [Abstract][Full Text] [Related]
20. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
